News & Media

Take a closer look at what we’re doing across Teva worldwide

Our latest news

Teva’s Digital Health Collaboration with Rimidi Expands to Include Respiratory Monitoring Program In...

Teva’s Digital Health Collaboration with Rimidi Expands to Include Respiratory Monitoring Program Integra

Teva Announces Early Tender Results of its Debt Tender Offer, Increases to Tender Caps and Election ...

Teva Announces Early Tender Results of its Debt Tender Offer, Increases to Tender Caps and Election of Ea

Teva and Natco Announce Launch of additional strengths for the Generic Version of Revlimid® (lenalid...

Teva and Natco Announce Launch of additional strengths for the Generic Version of Revlimid® (lenalidomide

Teva to Present at the Barclays Global Healthcare Conference

Teva to Present at the Barclays Global Healthcare Conference

Teva Announces Successful Upsize and Pricing of $2,490,000,000 (equivalent) Sustainability-Linked Se...

Teva Announces Successful Upsize and Pricing of $2,490,000,000 (equivalent) Sustainability-Linked Senior

Teva Announces Launch of $2,060,000,000 (Equivalent) Offering of Sustainability-Linked Senior Notes

Teva Announces Launch of $2,060,000,000 (Equivalent) Offering of Sustainability-Linked Senior Notes

Teva Announces $2,250,000,000 Debt Tender Offers for Notes Due 2023-2026

Teva Announces $2,250,000,000 Debt Tender Offers for Notes Due 2023-2026

Teva to Present New Data from CONNECT2 Study on its Digihaler® System at the American Academy of All...

Teva to Present New Data from CONNECT2 Study on its Digihaler® System at the American Academy of Allergy,

Teva Announces Publication of New Clinician Scale in Journal of Clinical Psychiatry to Assess the Im...

Teva Announces Publication of New Clinician Scale in Journal of Clinical Psychiatry to Assess the Impact

Teva Announces FDA Approval of AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, a New Once-D...

Teva Announces FDA Approval of AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, a New Once-Daily

Feature stories

Discover the world of Teva

What Living With Hearing Loss Has Taught Me

What Living With Hearing Loss Has Taught Me

3 Trends

3 Trends I'm Watching in Environment and Sustainability

3 Trends I'm Watching in Environment and Sustainability

3 Trends

New trends in clinical studies for patients

New trends in clinical studies for patients

3 Trends

3 Trends: New Directions in Digital Health

3 Trends: New Directions in Digital Health

9 Self-Care Tips from Patients and Caregivers

9 Self-Care Tips from Patients and Caregivers

Teva earns a top score on the 2022 Disability Equality Index

Teva earns a top score on the 2022 Disability Equality Index

Media Resources

Media Inquiries

Contact our corporate communications.

Learn more Media Inquiries

Media Kit

Files and resources for media use only

Download Teva Media Kit Media Kit

Financial Reports

View Teva financial news on our global website.

Learn more Financial Reports

Connect with us

Teva Social Media Guidelines.

Learn more Connect with us